Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 15 | 2024 | 1363 | 3.170 |
Why?
|
Sarcoma | 8 | 2024 | 1897 | 2.060 |
Why?
|
Vascular Malformations | 6 | 2021 | 454 | 1.540 |
Why?
|
Lipoma | 2 | 2023 | 334 | 1.310 |
Why?
|
Fibrosarcoma | 4 | 2023 | 348 | 1.170 |
Why?
|
Myofibromatosis | 2 | 2023 | 30 | 1.100 |
Why?
|
Hemangioma | 4 | 2023 | 738 | 1.030 |
Why?
|
Sarcoma, Clear Cell | 2 | 2022 | 76 | 0.980 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2023 | 100 | 0.880 |
Why?
|
Myxoma | 1 | 2023 | 130 | 0.860 |
Why?
|
Fibromatosis, Aggressive | 1 | 2023 | 118 | 0.860 |
Why?
|
Bone Neoplasms | 7 | 2024 | 2529 | 0.820 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 224 | 0.810 |
Why?
|
Granuloma, Plasma Cell | 1 | 2022 | 84 | 0.800 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 45 | 0.790 |
Why?
|
Sarcoma, Synovial | 2 | 2020 | 167 | 0.750 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 185 | 0.740 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2455 | 0.690 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2019 | 15 | 0.690 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2018 | 116 | 0.680 |
Why?
|
Vascular Neoplasms | 1 | 2020 | 175 | 0.670 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2018 | 26 | 0.670 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 220 | 0.650 |
Why?
|
Child | 48 | 2024 | 77709 | 0.650 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1660 | 0.630 |
Why?
|
Hamartoma | 2 | 2017 | 238 | 0.610 |
Why?
|
Neoplasms, Connective and Soft Tissue | 3 | 2023 | 37 | 0.590 |
Why?
|
Fibroma | 1 | 2018 | 212 | 0.580 |
Why?
|
Neck | 1 | 2021 | 697 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4554 | 0.560 |
Why?
|
Head | 1 | 2021 | 880 | 0.520 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2021 | 1581 | 0.510 |
Why?
|
Child, Preschool | 29 | 2023 | 41006 | 0.500 |
Why?
|
Hemangioendothelioma, Epithelioid | 3 | 2019 | 54 | 0.490 |
Why?
|
Gene Rearrangement | 4 | 2022 | 1179 | 0.490 |
Why?
|
Infant | 22 | 2023 | 35136 | 0.480 |
Why?
|
Arteriovenous Malformations | 4 | 2020 | 396 | 0.460 |
Why?
|
Specimen Handling | 2 | 2020 | 694 | 0.450 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2013 | 36 | 0.450 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.450 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3597 | 0.440 |
Why?
|
Pathology, Clinical | 1 | 2016 | 368 | 0.430 |
Why?
|
Mutation | 12 | 2023 | 29786 | 0.420 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2734 | 0.410 |
Why?
|
Neurofibrosarcoma | 2 | 2023 | 24 | 0.400 |
Why?
|
Receptor, trkA | 3 | 2023 | 164 | 0.400 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 231 | 0.390 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2013 | 134 | 0.390 |
Why?
|
Repressor Proteins | 2 | 2021 | 3023 | 0.380 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2021 | 83 | 0.370 |
Why?
|
Biopsy, Fine-Needle | 2 | 2022 | 1094 | 0.350 |
Why?
|
Subcutaneous Tissue | 2 | 2021 | 135 | 0.350 |
Why?
|
Carcinoma | 1 | 2021 | 2375 | 0.350 |
Why?
|
Adolescent | 30 | 2023 | 85781 | 0.330 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4253 | 0.320 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2020 | 1692 | 0.320 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2020 | 337 | 0.310 |
Why?
|
Male | 46 | 2023 | 350118 | 0.310 |
Why?
|
Female | 54 | 2023 | 380194 | 0.310 |
Why?
|
Kidney Neoplasms | 2 | 2022 | 4262 | 0.310 |
Why?
|
Fasciitis | 2 | 2019 | 65 | 0.300 |
Why?
|
Humans | 76 | 2024 | 744343 | 0.280 |
Why?
|
Neurofibromatosis 1 | 2 | 2023 | 569 | 0.280 |
Why?
|
Infant, Newborn | 10 | 2023 | 25625 | 0.270 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2513 | 0.260 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2019 | 449 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1061 | 0.250 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9239 | 0.240 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8863 | 0.230 |
Why?
|
Oncogene Fusion | 2 | 2021 | 99 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2016 | 3528 | 0.220 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2022 | 37 | 0.220 |
Why?
|
Bone Marrow | 1 | 2013 | 2948 | 0.220 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 72 | 0.220 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2023 | 188 | 0.220 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 188 | 0.210 |
Why?
|
Nephroma, Mesoblastic | 1 | 2022 | 25 | 0.210 |
Why?
|
Endodermal Sinus Tumor | 1 | 2022 | 47 | 0.210 |
Why?
|
Nose Neoplasms | 2 | 2015 | 246 | 0.210 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2021 | 40 | 0.200 |
Why?
|
Necrosis | 2 | 2023 | 1643 | 0.200 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2023 | 2649 | 0.200 |
Why?
|
Hemangioendothelioma | 1 | 2022 | 121 | 0.200 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 178 | 0.200 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2023 | 190 | 0.200 |
Why?
|
Diarrhea, Infantile | 1 | 2021 | 109 | 0.190 |
Why?
|
Lip | 1 | 2022 | 195 | 0.190 |
Why?
|
Hypertension, Portal | 1 | 2023 | 220 | 0.190 |
Why?
|
Malabsorption Syndromes | 1 | 2021 | 135 | 0.190 |
Why?
|
Hemangiosarcoma | 1 | 2023 | 239 | 0.190 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3703 | 0.180 |
Why?
|
Diagnosis, Differential | 6 | 2023 | 12959 | 0.180 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 48 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4386 | 0.180 |
Why?
|
Disorders of Sex Development | 1 | 2021 | 122 | 0.180 |
Why?
|
Endothelial Cells | 3 | 2022 | 3479 | 0.180 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 890 | 0.180 |
Why?
|
Codon | 1 | 2021 | 611 | 0.170 |
Why?
|
Teratoma | 1 | 2022 | 395 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 50 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4479 | 0.170 |
Why?
|
Prognosis | 9 | 2020 | 29063 | 0.170 |
Why?
|
Immunohistochemistry | 7 | 2022 | 11366 | 0.170 |
Why?
|
Oncogenes | 2 | 2022 | 1265 | 0.170 |
Why?
|
Sarcoma, Kaposi | 1 | 2022 | 370 | 0.170 |
Why?
|
Metabolism, Inborn Errors | 1 | 2021 | 288 | 0.160 |
Why?
|
Neurofibromin 1 | 1 | 2020 | 196 | 0.160 |
Why?
|
Eye Abnormalities | 1 | 2021 | 246 | 0.160 |
Why?
|
Cartilage Diseases | 1 | 2020 | 160 | 0.160 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 298 | 0.160 |
Why?
|
beta Catenin | 1 | 2023 | 1059 | 0.160 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 155 | 0.160 |
Why?
|
WT1 Proteins | 1 | 2018 | 178 | 0.160 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.160 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 193 | 0.160 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5686 | 0.150 |
Why?
|
Stem Cell Niche | 1 | 2021 | 346 | 0.150 |
Why?
|
Solitary Fibrous Tumors | 1 | 2018 | 72 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 216 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.150 |
Why?
|
Lymphatic Diseases | 1 | 2018 | 324 | 0.150 |
Why?
|
Scalp | 1 | 2019 | 380 | 0.140 |
Why?
|
Atrial Septum | 1 | 2017 | 60 | 0.140 |
Why?
|
Wnt Proteins | 1 | 2021 | 721 | 0.140 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2017 | 111 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 333 | 0.140 |
Why?
|
Adipocytes | 1 | 2023 | 1184 | 0.140 |
Why?
|
Appendix | 1 | 2017 | 110 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2017 | 251 | 0.130 |
Why?
|
Leg Injuries | 1 | 2017 | 178 | 0.130 |
Why?
|
Endemic Diseases | 1 | 2016 | 182 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 556 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 707 | 0.130 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 509 | 0.130 |
Why?
|
Exons | 1 | 2021 | 2437 | 0.130 |
Why?
|
Skull | 1 | 2019 | 813 | 0.130 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 382 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2022 | 975 | 0.120 |
Why?
|
Adult | 19 | 2022 | 214055 | 0.120 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2016 | 337 | 0.120 |
Why?
|
Young Adult | 14 | 2022 | 56430 | 0.120 |
Why?
|
Upper Extremity | 1 | 2019 | 648 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2421 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1348 | 0.120 |
Why?
|
Liver Diseases | 1 | 2021 | 1253 | 0.110 |
Why?
|
Meningioma | 1 | 2021 | 1209 | 0.110 |
Why?
|
Glycoproteins | 1 | 2021 | 2263 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 341 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1241 | 0.110 |
Why?
|
Chordoma | 1 | 2015 | 359 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1158 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1065 | 0.100 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2017 | 574 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 547 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1142 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2016 | 388 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2043 | 0.100 |
Why?
|
Lung | 2 | 2022 | 9856 | 0.100 |
Why?
|
Histones | 2 | 2023 | 2599 | 0.100 |
Why?
|
Pancreatitis | 1 | 2018 | 1092 | 0.100 |
Why?
|
Osteochondroma | 1 | 2011 | 47 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 295 | 0.090 |
Why?
|
Fatty Liver | 1 | 2016 | 727 | 0.090 |
Why?
|
DNA Methylation | 2 | 2023 | 4286 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6538 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2011 | 437 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5535 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 1 | 2017 | 1695 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 658 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39050 | 0.080 |
Why?
|
Malaria, Falciparum | 1 | 2016 | 1077 | 0.080 |
Why?
|
Molecular Biology | 2 | 2022 | 596 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.080 |
Why?
|
Glioma | 1 | 2022 | 3401 | 0.080 |
Why?
|
Biopsy | 4 | 2020 | 6756 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6103 | 0.070 |
Why?
|
Plasmodium falciparum | 1 | 2016 | 1732 | 0.070 |
Why?
|
Genomics | 4 | 2023 | 5720 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4838 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1352 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1420 | 0.060 |
Why?
|
Liver | 2 | 2021 | 7474 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2948 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4986 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4931 | 0.060 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5256 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5510 | 0.060 |
Why?
|
Middle Aged | 9 | 2021 | 213383 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.060 |
Why?
|
Leukoplakia, Oral | 1 | 2023 | 73 | 0.060 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 13 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2022 | 77449 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.050 |
Why?
|
S100 Proteins | 1 | 2022 | 259 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2023 | 250 | 0.050 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2022 | 170 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7880 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6171 | 0.050 |
Why?
|
Salivary Glands | 1 | 2022 | 229 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2022 | 2727 | 0.050 |
Why?
|
Genitalia | 1 | 2021 | 112 | 0.050 |
Why?
|
Gene Fusion | 1 | 2023 | 371 | 0.050 |
Why?
|
Base Sequence | 2 | 2022 | 12797 | 0.040 |
Why?
|
Public Opinion | 1 | 2024 | 477 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 631 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16365 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 295 | 0.040 |
Why?
|
Sclerotherapy | 1 | 2019 | 175 | 0.040 |
Why?
|
STAT6 Transcription Factor | 1 | 2018 | 199 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2021 | 599 | 0.040 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.040 |
Why?
|
Tongue | 1 | 2020 | 406 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1086 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13102 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8642 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12072 | 0.040 |
Why?
|
Rare Diseases | 1 | 2021 | 553 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 733 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2018 | 657 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 40561 | 0.030 |
Why?
|
Reticulin | 1 | 2015 | 21 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1623 | 0.030 |
Why?
|
Fetal Heart | 1 | 2017 | 276 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 496 | 0.030 |
Why?
|
North America | 1 | 2018 | 1249 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 5985 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1880 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12788 | 0.030 |
Why?
|
Mitosis | 1 | 2018 | 1208 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8428 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2017 | 819 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2564 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1941 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
Ulna | 1 | 2011 | 133 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3036 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2689 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9313 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2029 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3521 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35421 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2133 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11031 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6544 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57776 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11483 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12208 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13033 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29144 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25043 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168757 | 0.010 |
Why?
|